Wall Street ends near flat; healthcare shares gain but trade deal delay weighs
By Caroline Valetkevitch NEW YORK (Reuters) - U.S. stocks ended little changed on Wednesday as a report the U.S.-China trade deal could be delayed until December was offset by gains in healthcare shares.
By Caroline Valetkevitch
NEW YORK (Reuters) - U.S. stocks ended little changed on Wednesday as a report the U.S.-China trade deal could be delayed until December was offset by gains in healthcare shares.
The Nasdaq broke a three-day string of record closing highs, and the Dow barely snapped its two-day run of record highs.
A senior official of the Trump administration told Reuters a meeting between U.S. President Donald Trump and Chinese President Xi Jinping to sign a long-awaited interim trade deal could be delayed until December, as discussions continue over terms and a venue.
That renewed worries over how long the trade war may continue and caused stocks to trade lower briefly.
"The big headline was Reuters reporting that the signing of 'phase one' would potentially be pushed into December. The market sold off on that but nothing major, and right now investors are in a holding pattern, waiting to see if we set new highs and can punch through them," said Michael O'Rourke, chief market strategist at JonesTrading in Greenwich, Connecticut.
The Trump administration official said it was still possible the "phase one" agreement would not be reached, but a deal was more likely than not.
The recent rally to record highs had been fueled by signs of progress in the U.S.-China trade talks along with some upbeat earnings reports.
On Wednesday, Humana Inc
CVS Health Corp
The Dow Jones Industrial Average <.DJI> fell 0.07 points to 27,492.56, the S&P 500 <.SPX> gained 2.16 points, or 0.07%, to 3,076.78 and the Nasdaq Composite <.IXIC> dropped 24.05 points, or 0.29%, to 8,410.63.
Also in health care, DaVita
The S&P 500 financials index <.SPSY> extended recent gains, rising 0.4%, while the S&P 500 energy index <.SPNY> fell 2.3% following declines in oil prices.
Match Group Inc
Declining issues outnumbered advancing ones on the NYSE by a 1.21-to-1 ratio; on Nasdaq, a 1.76-to-1 ratio favored decliners.
The S&P 500 posted 14 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 70 new highs and 68 new lows.
Volume on U.S. exchanges was 7.93 billion shares, compared to the 6.74 billion average for the full session over the last 20 trading days.
(Editing by Chris Reese, Jonathan Oatis and David Gregorio)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
(Reuters) - The Trump administration on Thursday proposed to loosen Obama-era safety regulations for the oil industry in the Arctic Ocean off Alaska to ease the way for petroleum extraction in the region, an effort that President-elect Joe Biden will likely throw out once in office. The proposal would revise a suite of Obama-era rules crafted to improve safety in the extreme conditions of the Arctic after a Shell drilling rig ran aground there in 2012. The company later abandoned oil exploration in the region and there are no active drilling operations there
By Patricia Zengerle and Steve Holland WASHINGTON (Reuters) - Officials from President Donald Trump's vaccine distribution effort have not briefed anyone on President-elect Joe Biden's transition team, and have no plans to do so, Democratic U.S. senators said after a White House call on Thursday.
(Reuters) - The European Commission will make proposals for a gradual and coordinated lifting of coronavirus restrictions in the 27-nation European Union to avoid another wave of the pandemic, the head of the bloc's executive said on Thursday. "We will continue coordinating our efforts to keep citizens informed on vaccination," said Ursula von der Leyen, adding the Commission was broadening vaccine discussions with Moderna and Novavax .